We are live on
!
Find out more
RM
RP Management Portfolio holdings
AUM
$139M
1-Year Est. Return
37.98%
This Fund
S&P 500
This Quarter
Est. Return
-17.42%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$245M
AUM Growth
-$54.2M
(-18%)
Cap. Flow
-$347K
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
+$347K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $144M | 59.01% |
2,111,111
| – | – |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $79.8M | 32.65% |
9,166,667
| – | – |
|
3
Cytokinetics
CYTK
$11.5B
| $20.4M | 8.33% |
875,656
| – | – |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $34K | 0.01% |
3,700
-33,305
| -90% | -$347K |
|
Similar funds
PC
LA
TP
SC
MFG
MADFP
RM
NC